Study Evaluating LDL-C Change and Adherence to Inclisiran Lipid-lowering Therapy in ASCVD
Clinical trial NCT05399992 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05399992
- Sponsor
- Novartis Pharmaceuticals
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2022-09-12
- Primary completion
- 2026-10-05
- Enrollment
- 847
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.